A study says ribociclib, a drug approved for treating advanced-stage breast cancer, may help reduce the risk of recurrence in women who have been treated for certain types of early-stage breast cancer. Research is ongoing.
As adults get older, they're often prescribed more and more medications to help manage various ailments. But often these people must also advocate for a hard look at what is no longer needed.
FDA-mandated trial shows no increased risk for heart attacks or strokes when men with deficiency take testosterone.
The FDA released the new guidance Monday aiming to reduce the use of pathogen-contaminated tattoo ink, which can cause stubborn infections that are especially hard to treat, dermatologists said.
